D-0299-2015 Class II Terminated

Recalled by Zydus Pharmaceuticals USA Inc — Pennington, NJ

FDA drug recall D-0299-2015 was initiated by Zydus Pharmaceuticals USA Inc on Nov 26, 2014 and is designated Class II. Reason for recall: Failed Tablet/Capsule Specifications: Recall due to wet and/or leaking capsules. The recall status is terminated (terminated Sep 25, 2017). Affected quantity: 58,920 bottles.

Recall details

Product Type
Drugs
Report Date
Dec 24, 2014
Initiation Date
Nov 26, 2014
Termination Date
Sep 25, 2017
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
58,920 bottles

Product description

Benzonatate Capsules, USP, 200 mg, 100-count bottles, Rx only, Manufactured by: Cadila Healthcare Ltd, Ahmedabad, India; Distributed by: Zydus Pharmaceuticals USA, In, Pennington, NJ USA 08534; NDC 68382-248-01, UPC 3 68382 24801 5.

Reason for recall

Failed Tablet/Capsule Specifications: Recall due to wet and/or leaking capsules.

Distribution pattern

Nationwide and Puerto Rico

Code information

Lot #: MP2137, MP2138, MP2139, Exp 01/16; MP3614, Exp 03/16; MP5611, MP5613, Exp 05/16

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0299-2015
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0299-2015. Report a data issue: hello@regdatalab.com.